PayMedix/TempoPay, a company known for its innovative healthcare payment solutions, has announced the appointment of David Kinsey as its new Vice President of Sales. This strategic move comes at a time when the company is experiencing rapid growth in its mission to provide interest-free financing for healthcare services to employees, regardless of their credit histories.
Kinsey brings a wealth of experience to his new role, with an extensive background in the healthcare and employee benefits industry. His primary focus will be on driving growth for PayMedix/TempoPay’s solutions and building strategic relationships across the healthcare sector, with a particular emphasis on the Southeast region.
Tom Policelli, CEO of PayMedix/TempoPay, expressed enthusiasm about the appointment, stating, ‘As more health systems, employers, and benefits administrators across the country continue to look for ways to lower costs and provide affordable access to healthcare for employees, we’re seeing increased interest in our flexible financing and payments solutions.’ Policelli highlighted Kinsey’s extensive knowledge of healthcare sales and the employee benefits industry as key assets that will help expand the company’s reach and ability to serve providers and employers seeking alternative healthcare payment solutions.
Prior to joining PayMedix/TempoPay, Kinsey held the position of Executive Director at Aetna, where he led the Healthcare Business Solutions team to achieve impressive 60% growth over five years. His leadership and collaboration efforts were recognized with Aetna’s Chairman’s Leadership Award. Kinsey’s career also includes experience as a Senior Client Manager at Cigna Healthcare, where he received the Gold Circle award for top sales results.
Kinsey expressed his excitement about the new role, describing the PayMedix/TempoPay solution as a ‘game-changer’ in addressing the pressing issue of high out-of-pocket healthcare costs. He stated, ‘I look forward to working with the team to expand our reach and bring employers a financial safety net for their employees that ultimately improves retention and reduces absenteeism.’
Brian Marsella, President of PayMedix/TempoPay, voiced confidence in Kinsey’s ability to demonstrate the value of their solution to employers, PEOs, health plans, and network builders. Marsella emphasized the importance of ensuring individuals have access to financial resources for healthcare when needed, rather than when they believe they can afford it. This approach aims to break the cycle of care avoidance, which has historically led to sicker patients entering the healthcare system, worse outcomes, and increased costs.
PayMedix, which originated as the financing arm of Wisconsin-based HPS over a decade ago, has processed more than $5 billion in medical payments for hospital systems and physician practices. The company’s solution can be implemented in conjunction with any PPO or HMO network, offering a comprehensive approach to solving the problem of high out-of-pocket costs for all stakeholders in the healthcare system.
TempoPay, a partner company, focuses on helping employers provide their employees with interest-free financing and flexible repayment options for medical costs. Through the TempoPay Visa® card, employees can manage their healthcare expenses without added stress, promoting happier and healthier lives.
This appointment and the continued growth of PayMedix/TempoPay reflect the increasing demand for innovative solutions to address the challenges of healthcare affordability and accessibility in the United States. As healthcare costs continue to rise, the company’s approach to providing financial flexibility and security for both providers and patients could have significant implications for the broader healthcare industry and employee benefits landscape.
This news story relied on a press release distributed by News Direct. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is PayMedix/TempoPay Appoints David Kinsey as Vice President of Sales Amid Rapid Growth.